Teva Settles Coreg Suit Against Dr. Reddy's
Teva Pharmaceutical Industries Ltd. has resolved a suit seeking to block Dr. Reddy's Laboratories Inc. from launching a generic version of GlaxoSmithKline Inc.'s congestive heart failure drug Coreg....To view the full article, register now.
Already a subscriber? Click here to view full article